Calypso screens baby’s eyes for abnormalities to help treat them early and protect vision. Today, newborn eye disease screening is shining a light into a tiny pupil to see how the retina reflects it. Newborns with smaller abnormalities mostly pass the reflex test, but may then suffer irreversible vision loss. Large studies show that 5% of newborns are at risk for such ocular disease.
Now, Calypso newborn screening innovation uses wide-angle imaging to find them and inform doctors. Already used in prematures, all newborns benefit significantly from this screen for eye disease and artificial intelligence streamlines and accelerates this. Also, parents may not know they are carriers of genetic factors that cause vision loss.
